Cart
sales@molnova.com
LY2880070
CAS No. 1375637-35-6
LY2880070( —— )
Catalog No. M23534 CAS No. 1375637-35-6
LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2880070
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
-
DescriptionLY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetChk
-
RecptorChk1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1375637-35-6
-
Formula Weight381.43
-
Molecular FormulaC19H23N7O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc(cc1)nc(OC)c1-c1cc(Nc2cncc(O[C@H]3CNCCC3)n2)n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GNE-900
GNE-900 (GNE900)?is a potent, selective, ATP-competitive, and orally bioavailable Chk1 inhibitor with IC50 of <1 nM.
-
MARPIN
MARPIN is a novel ATR-Chk1 pathway inhibitor that inhibits hydroxyurea (HU)-induced phosphorylation of Ser345 on Chk1 with IC50 of 7.7 uM.
-
4-Demethyldeoxypodop...
4-Demethyldeoxypodophyllotoxin, an aryl tetrahydronaphthalenyl lignan analog from the roots of Podophyllum peltatum, has anticancer activity and modulates the Chk-2 signaling pathway in MCF-7 breast cancer cells.
